Subject(s)
Humans , Female , Child , Staphylococcus aureus/isolation & purification , Central Nervous System Diseases/etiology , Endocarditis, Bacterial/complications , Endocarditis, Bacterial/diagnosis , Endocarditis, Bacterial/microbiology , Endocarditis, Bacterial/drug therapy , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/therapeutic use , Echocardiography , Antibiotic ProphylaxisSubject(s)
Glucose/therapeutic use , Insulin/therapeutic use , Myocardial Infarction/drug therapy , Potassium/therapeutic use , Adult , Aged , Dipyridamole/therapeutic use , Drug Combinations , Female , Glucose/adverse effects , Humans , Insulin/adverse effects , Male , Middle Aged , Potassium/adverse effectsABSTRACT
A brief introduction on the pathogenesis of atherosclerosis is followed by a review of the various tests used in screening subjects at cardiovascular risk including the new test to determine Apo A/Apo B measurement. The reliability of the various biohumoral indices in several sample groups is analysed and compared. It is concluded that variations in the Apo A/Apo B ratio are the most reliable indicator of patients at risk of heart disease.
Subject(s)
Cardiovascular Diseases/blood , Apolipoproteins/blood , Apolipoproteins A , Apolipoproteins B , Cholesterol/blood , Cholesterol, HDL , Humans , Lipoproteins, HDL/blood , Prognosis , Risk , Triglycerides/bloodABSTRACT
After a review of the pathogenesis of congestive decompensation in the light of recent discoveries, the basis for the use of vasodilator drugs in such pathologies is discussed. The results of personal clinical experiments using hydralazine and isosorbide dinitrate are described with the conclusion that these drugs are really effective.